Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 9363871

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
1997 Nov
First author
Stadler WM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Stadler WM
      type
      Author
    2. name
      Kuzel T
      type
      Author
    3. name
      Roth B
      type
      Author
    4. name
      Raghavan D
      type
      Author
    5. name
      Dorr FA
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Stadler WM
      type
      Author
    2. name
      Kuzel T
      type
      Author
    3. name
      Roth B
      type
      Author
    4. name
      Raghavan D
      type
      Author
    5. name
      Dorr FA
      type
      Author
    bibliography ids
    1. nci-bib-878c0ecb85a9fd22cf5494a5
    book metadata
    content sha256
    b6fd40bc399480fa7a6e3a1e7bd6f116ab29cdcac5109bc9ec690782df27dcbb
    document type
    citation
    dois
    1. 10.1200/JCO.1997.15.11.3394
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:9363871
    immutable id
    pubmed:9363871@b6fd40bc399480fa7a6e3a1e7bd6f116ab29cdcac5109bc9ec690782df27dcbb
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    11
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3394-8
    volume
    15
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      9363871
      provenance
      batch id
      fff67794fd83a61706ce
      provider
      NCBI PubMed ESummary
      record sha256
      b6e6e2413854f8d3f9dcc82630c6633ba4830d5cd4087663b02ab947569b6d81
      response sha256
      bedc2583321e1fd4327b987cd9a11c78de8d225d1f0ce57e6a3d1d51b5f54126
      retrieved at
      2026-09-09T23:45:29.081942+00:00
      publication date
      display
      1997 Nov
      precision
      month
      year
      1997
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase II
      3. Journal Article
      4. Multicenter Study
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/9363871/
      title
      Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer.

      Preserved source evidence · Not medical advice